Article Details
Retrieved on: 2024-10-29 17:14:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Long-term treatment of adolescents with moderate-to-severe atopic dermatitis with upadacitinib is safe and effective through 76 weeks.
Article found on: www.dermatologyadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here